IBB vs XBI: ETF Comparison
iShares Biotechnology ETF compared with State Street SPDR S&P Biotech ETF: costs, income, size, performance and the top holdings they share.
IBB vs XBI at a Glance
IBB (iShares Biotechnology ETF) is run by BlackRock and launched in February 2001; XBI (State Street SPDR S&P Biotech ETF) is run by State Street and launched in January 2006. As of Nov 16, 2026, XBI is cheaper: its 0.35% expense ratio costs about $35 a year per $10,000 invested, versus $44 for IBB (0.44%). IBB manages $10.64B in assets across 248 holdings, XBI $10.19B in assets across 166 holdings.
As of Nov 16, 2026, IBB has a trailing dividend yield of 0.16% and XBI 0.37%. Over the past year IBB's price changed +25.85% versus +27.04% for XBI; over five years the figures are +34.96% and +18.67% (price change, dividends excluded).
Among the top 50 holdings of IBB and the top 52 of XBI (holdings as of Oct 4, 2026), 33 positions are shared. They make up 63.46% of IBB and 46.81% of XBI; the largest common ones are MRNA, NTRA and UTHR.
Key Figures Side by Side
| Metric | IBB | XBI |
|---|---|---|
| Expense ratio | 0.44% | 0.35% |
| Annual cost per $10,000 | $44 | $35 |
| Dividend yield (TTM) | 0.16% | 0.37% |
| Assets under management | $10.64B | $10.19B |
| Holdings | 248 | 166 |
| 1-year price change | +25.85% | +27.04% |
| 5-year price change | +34.96% | +18.67% |
| Asset class | Equity | Equity |
| Issuer | BlackRock | State Street |
| Inception | Feb 4, 2001 | Jan 30, 2006 |
Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology
Shared Top Holdings
33 of the top 50 IBB and top 52 XBI positions overlap, by weight in each fund
| Holding | IBB weight | XBI weight |
|---|---|---|
| MRNA | 5.00% | 2.81% |
| NTRA | 3.98% | 1.82% |
| UTHR | 1.62% | 1.57% |
| BIIB | 2.32% | 1.53% |
| AMGN | 7.63% | 1.51% |
| GILD | 8.26% | 1.46% |
| RVMD | 2.87% | 1.46% |
| VRTX | 7.54% | 1.42% |
| INCY | 1.79% | 1.34% |
| REGN | 5.58% | 1.22% |
| INSM | 1.82% | 1.22% |
| ROIV | 1.40% | 1.12% |
| NBIX | 1.04% | 1.35% |
| EXEL | 1.01% | 1.47% |
| HALO | 0.91% | 1.50% |
Source: Fund holdings disclosures (largest positions only). Data as of Oct 4, 2026. Data sources and methodology
Interactive IBB vs XBI Comparison
Performance Comparison
No chart data available
Comparison Results
Marked values are the best in their row where higher or lower is clearly better.
Frequently Asked Questions
Which is cheaper, IBB or XBI?
XBI is cheaper as of Nov 16, 2026: its expense ratio is 0.35% versus 0.44% for IBB. On a $10,000 investment that is about $35 a year against $44, a difference of roughly $9 a year.
Which pays a higher dividend, IBB or XBI?
XBI pays more as of Nov 16, 2026: its trailing twelve-month dividend yield is 0.37% versus 0.16% for IBB.
Do IBB and XBI hold the same stocks?
Among the top 50 holdings of IBB and the top 52 of XBI (holdings as of Oct 4, 2026), 33 positions are shared. They make up 63.46% of IBB and 46.81% of XBI; the largest common ones are MRNA, NTRA and UTHR.
Which has performed better, IBB or XBI?
XBI has done better over the past year to Nov 16, 2026: its price changed +27.04% against +25.85% for IBB. Over five years IBB changed +34.96% and XBI +18.67%. These are price changes and exclude dividends.

